Insider Selling: Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Sells 5,940 Shares of Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CEO Lisa Utzschneider sold 5,940 shares of the firm's stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $9.75, for a total transaction of $57,915.00. Following the completion of the transaction, the chief executive officer now owns 266,926 shares in the company, valued at $2,602,528.50. This represents a 2.18 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Integral Ad Science Stock Performance

Integral Ad Science stock traded up $0.48 during midday trading on Wednesday, reaching $10.20. 1,300,370 shares of the company traded hands, compared to its average volume of 1,082,354. The firm has a market capitalization of $1.66 billion, a price-to-earnings ratio of 51.00, a price-to-earnings-growth ratio of 1.46 and a beta of 1.46. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The business has a 50 day moving average of $11.00 and a two-hundred day moving average of $10.79. Integral Ad Science Holding Corp. has a 12 month low of $7.98 and a 12 month high of $17.53.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. During the same quarter in the previous year, the firm earned ($0.09) earnings per share. The company's revenue for the quarter was up 11.0% on a year-over-year basis. As a group, research analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on IAS. Oppenheimer cut their price objective on Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 13th. Craig Hallum cut their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Scotiabank assumed coverage on shares of Integral Ad Science in a research note on Thursday, December 5th. They issued a "sector perform" rating and a $10.00 price target for the company. Piper Sandler reduced their target price on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating on the stock in a report on Wednesday, November 13th. Finally, Truist Financial lowered their target price on Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a research note on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Integral Ad Science presently has a consensus rating of "Moderate Buy" and an average target price of $15.18.

Institutional Trading of Integral Ad Science

A number of large investors have recently made changes to their positions in the business. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Integral Ad Science during the second quarter valued at $4,724,000. abrdn plc grew its holdings in Integral Ad Science by 12.5% during the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company's stock valued at $23,216,000 after purchasing an additional 237,930 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Integral Ad Science by 47.6% during the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock valued at $7,756,000 after buying an additional 231,271 shares during the last quarter. Invenomic Capital Management LP lifted its stake in shares of Integral Ad Science by 57.4% during the 3rd quarter. Invenomic Capital Management LP now owns 585,309 shares of the company's stock worth $6,327,000 after acquiring an additional 213,488 shares during the last quarter. Finally, Rice Hall James & Associates LLC purchased a new position in Integral Ad Science during the 3rd quarter valued at $1,795,000. 95.78% of the stock is currently owned by institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.